phone icon (917) 310-3371 Explore Sublocade Injections Menu
Nao Medical Logo

Sublocade injections in NYC and Long Island

Review monthly buprenorphine injection care across the Nao Medical network, including transition from oral buprenorphine, specialty-pharmacy coordination, and active injection locations.

Many major insurance plans are accepted for addiction medicine visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Because Sublocade can involve both the office visit and the medication, the team reviews benefits, prior authorization needs, and specialty-pharmacy steps before the injection is scheduled.

Self-pay requests can also be reviewed. Because Sublocade includes a monthly medication plus in-clinic administration, visit fees, medication costs, and pharmacy logistics should be clarified before treatment starts.

The practical workflow usually includes evaluation, review of recent opioid and buprenorphine use, benefits verification, specialty-pharmacy coordination, scheduling of the in-clinic injection, and repeat monthly follow-up.

A monthly injection plan needs more than a medication label The transition, benefits review, pharmacy timing, and monthly follow-up all need to work together before a Sublocade plan is actually useful in real life.

What the Sublocade family covers

Nao Medical offers Sublocade injection planning for moderate to severe opioid use disorder, including transition review from oral buprenorphine, monthly follow-up scheduling, specialty-pharmacy coordination, and active location support across NYC and Long Island. If patients are also working with therapy, psychiatry, primary care, or another addiction clinician, the medication plan can be coordinated instead of treated like a standalone one-off injection visit.

Who this lane is built for

The program is designed for adults with opioid use disorder who are reviewing whether a monthly buprenorphine injection fits their treatment plan.

How the transition is reviewed

Some patients arrive already taking oral or transmucosal buprenorphine. Others need a supervised first step to confirm tolerability before a monthly injection plan makes sense. The transition is reviewed clinically rather than assumed from a prior prescription alone.

Why the workflow matters

The practical workflow usually includes evaluation, review of recent opioid and buprenorphine use, benefits verification, specialty-pharmacy coordination, scheduling of the in-clinic injection, and repeat monthly follow-up.

Why pharmacy coordination matters

Sublocade is not picked up like a standard retail prescription. The medication is coordinated through certified workflows, and shipment timing has to align with the office visit so the injection can be administered in clinic.

Key support pages in the family

Transition from oral buprenorphine

The first question is not just whether someone wants the injection. It is whether recent opioid use, current buprenorphine treatment, and medication tolerance support a safe transition.

Monthly injection workflow

The first phase covers evaluation, transition review when needed, benefits confirmation, and medication coordination so the plan is lined up before a treatment slot is used.

Specialty-pharmacy coordination

Sublocade is not picked up from a standard retail pharmacy. The medication is coordinated through certified handling pathways and administered by a provider in clinic.

Active injection locations

The Sublocade family currently covers Brooklyn, Queens, the Bronx, Manhattan, and Long Island so the treatment plan does not depend on one hard-to-reach clinic.

Active Sublocade locations across New York

Open the clinic page that best fits the monthly follow-up plan for directions, local booking, and the practical details that matter once treatment is ongoing.

Insurance, self-pay, and monthly planning

Many major insurance plans are accepted for addiction medicine visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Because Sublocade can involve both the office visit and the medication, the team reviews benefits, prior authorization needs, and specialty-pharmacy steps before the injection is scheduled.

Self-pay requests can also be reviewed. Because Sublocade includes a monthly medication plus in-clinic administration, visit fees, medication costs, and pharmacy logistics should be clarified before treatment starts.

The team reviews the medication, the visit, and the scheduling workflow together so patients are not surprised later by missing pharmacy or authorization steps.

Related opioid-treatment paths

Opioid addiction treatment hub

Broader MAT visits across the network cover same-day access, bridge planning, fentanyl dependence, and the full local treatment footprint.

Vivitrol treatment

A separate injectable pathway is available when the question is monthly naltrexone rather than monthly buprenorphine.

Same-day Suboxone access

When the immediate issue is how fast someone can be evaluated and started safely, the same-day pathway matters more than the injection discussion.

Bridge prescriptions

Short-gap medication questions are handled through the bridge pathway rather than improvised refill assumptions.

Questions about Sublocade injections

Sublocade is a once-monthly extended-release buprenorphine injection used to treat opioid use disorder. It is administered by a healthcare provider in clinic rather than taken home like a daily medication.
Many patients transition from oral or transmucosal buprenorphine, but the team reviews recent opioid use, current treatment, medication tolerability, and safety before an injection is scheduled. Patients who are not currently receiving buprenorphine may need a supervised test dose to confirm tolerability first.
Sublocade is organized as a monthly in-clinic injection plan. The program also includes follow-up review, scheduling, monitoring, and coordination between visits.
Yes. Many major insurance plans are accepted for addiction medicine visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Because Sublocade can involve both the office visit and the medication, the team reviews benefits, prior authorization needs, and specialty-pharmacy steps before the injection is scheduled. Sublocade is not picked up like a standard retail prescription. The medication is coordinated through certified workflows, and shipment timing has to align with the office visit so the injection can be administered in clinic.
Self-pay requests can also be reviewed. Because Sublocade includes a monthly medication plus in-clinic administration, visit fees, medication costs, and pharmacy logistics should be clarified before treatment starts.
No. Sublocade is administered by a healthcare provider in clinic and is not dispensed like a standard retail pharmacy pickup.

200,000+ 5-star reviews

What patients say about Nao Medical

Verified Patient
(4.9)

The monthly injection process felt much clearer here than on most medication pages.

Verified Patient
(4.9)

Helpful to see the transition, pharmacy, and location steps broken out instead of hidden in one generic hub.

Verified Patient
(4.9)

The page made it easier to figure out what the first visit is actually supposed to accomplish.

Verified Patient
(4.9)

I liked that it was direct about insurance and self-pay instead of pretending the logistics do not matter.

Verified Patient
(4.9)

The location links made the next step much easier.

Nao medical

Choose a Sublocade location that works monthly

Pick the clinic that is realistic for repeat follow-up, then use the local page for booking and directions.

See active Sublocade locations